The global ambulatory surgery centers market size was valued at USD 117.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.18% from 2023 to 2030. Key drivers include an increase in the incidence of chronic diseases and a rise in the geriatric population, which requires cost-effective and efficient treatment. Furthermore, advancements in diagnostic techniques and surgeries, such as minimally invasive surgeries, endoscopy, and laparoscopy, are expected to drive market growth.
The market for ambulatory surgery centers (ASCs) is poised to witness significant growth in the coming years. The cost-effectiveness of procedures performed at ASCs has made them appealing to patients and healthcare providers. Furthermore, the rising geriatric population contributes to the growing demand for surgeries and is expected to fuel market expansion. According to a report from the Ambulatory Surgery Center Association, the availability and utilization of ambulatory surgery centers have led to a reduction of annual healthcare costs in the United States by USD 38 billion. This demonstrates the positive impact of ASCs on healthcare affordability and accessibility.
Moreover, healthcare expenditure in ambulatory surgery centers is significantly lower than in hospitals. An extensive report by OR Manager , based on CMS statistics from January 2020, stated that 57 billion surgical procedures are performed in the U.S. every year. Less than 20% of these procedures are estimated to be done in inpatient hospital facilities, which indicates a shift in demand toward ambulatory surgery centers.The lower healthcare expenditure associated with ASCs has contributed to their increasing popularity. It has led to a significant transformation in the healthcare landscape, with more patients opting for outpatient procedures in these specialized facilities.
The COVID-19 pandemic positively impacted ASCs due to the increased demand for emergency care and the number of COVID-19-positive patients. According to an article by the National Center of Biotechnology Information in May 2022, ambulatory surgical centers and other facilities that perform surgeries and procedures were advised to comply with guidance to prevent the spread of COVID-19 and to protect resources such as bed space, staffing, personal protective equipment, and ventilators needed to care for COVID-19 patients. In addition, in April 2020, the Centers for Medicare and Medicaid Services (CMS) laid out a process to temporarily enroll Medicare-approved ASFs as hospitals during the COVID-19 public health emergency.
Major players in the healthcare industry are undertaking strategic initiatives to increase their market share through the acquisition of medical practices and outpatient facilities. These initiatives are aimed at expanding their reach and enhancing their service offerings. For instance, in February 2022, Mayo Clinic announced plans for a USD 432 million expansion to modify an existing facility in Jacksonville, Florida by adding 121 new inpatient beds. Such investments are expected to drive market growth.
The orthopedics segment led the global market in 2022 with a revenue share of 27.45%. This strong demand is attributed to the increasing need for orthopedic surgery and the growing number of strategic initiatives by major market players. In recent years, the number of knee and hip replacement surgeries has increased steadily, positively impacting the growth of this segment.
For instance, a June 2021 Canadian Health Information Institute report showed that 55,300 hip replacements and 55,285 knee replacements were performed in Canada during 2020-2021. Additionally, knee and hip replacement surgeries have increased by an average of about 5% in recent years in these countries.Hence, the demand for ambulatory surgery centers is expected to increase due to the high number of orthopedic surgeries, thus fueling segment growth.
Based on application, the market is segmented into pain management/spinal injections, orthopedics, ophthalmology, gastroenterology, plastic surgery, otolaryngology, obstetrics/gynecology, dental, podiatry, and others. The pain management/spinal injections segment is expected to witness strong growth over the forecast period. Pain management services include the treatment and assessment of persistent pain. Rapid recovery, early discharge, and low chances of requirement of surgeries, as well as minimum adverse effects of anesthesia, such as fatigue, nausea, and pain, are among the factors driving segment growth.
The single-specialty segment dominated the ambulatory surgery centers market in 2022 with a revenue share of 61.78%. The increased incidence and frequency of ocular disorders and the growing number of single specialty ambulatory surgery centers are factors attributed to market growth. For instance, as of June 2023, according to ASC Data, the number of single-specialty ambulatory surgical centers in the U.S. stood at 3,082.
Hernia repair, knee replacements, colonoscopy, and other less-intrusive treatments are among the surgeries carried out in single-specialty ambulatory surgical centers. These establishments must follow strict guidelines and criteria for patient safety and care quality. Furthermore, the reimbursement rate for procedures at these facilities is high. Hence, the market for single-specialty ambulatory surgical centers is growing rapidly.
Based on the center type, the market is segmented into single-specialty and multi-specialty. The multi-specialty segment is anticipated to develop at the fastest rate through the projection period, due to its broad and patient-focused strategy for surgical treatment, bringing a variety of services under a single roof and helping medical procedures run more smoothly. Increased surgical procedures in fields such as gastroenterology, pain management, and ophthalmology are anticipated to drive revenue in the multi-specialty segment.
The physician-owned segment dominated the market in 2022 with a revenue share of 62.17%. This is owing to advantages such as the chance to communicate directly with medical professionals who are familiar with each patient's situation and the capability to completely focus on a small number of treatments in a single environment. The increase in revenue in this segment is anticipated to be fueled by reduced surgical operation expenses compared to other ambulatory surgery facilities, favorable reimbursements, low operating expenses, and other associated variables. Based on ownership, the market is segmented into physician-owned, hospital-owned, and corporate-owned.
The hospital-owned segment is poised to expand at the fastest pace through the forecast period, due to a rising shift of patients from inpatient healthcare facilities to hospital-owned ambulatory surgery facilities. Key players are launching various programs through partnerships to aid market growth. For instance, in November 2021, an innovative total joint program was introduced by the Effingham Ambulatory Surgery Center, which is a joint venture partner of Sarah Bush Lincoln Health System (SBLHS) and an affiliate of USPI (United Surgical Partners International). The patient receives individualized support through this initiative from the moment the surgery is scheduled until they have recovered from the operation. Such initiatives help raise the standard of care provided.
North America contributed significantly to the market in 2022 with a revenue share of around 35.28%. This can be attributed to the rapid adoption of technologically developed products in the region. Increasing government support for primary care and expansion of outpatient care are the major factors for the expansion of the ambulatory surgical center market in the North America region.
Increasing government initiatives and strategic undertakings by key market players are expected to drive the regional market. In March 2021, Ascension, a prominent healthcare organization, entered into a partnership agreement with Regent Surgical Health, a leading developer of ambulatory surgery centers (ASCs). This collaboration aims to facilitate the development, acquisition, and operation of ambulatory surgery centers in the communities served by Ascension. The primary objective of this initiative is to offer patients convenient access to high-quality outpatient surgical services.
On the other hand, Asia Pacific is expected to register the fastest growth over the coming years. The expansion of outpatient facilities is driven by rising healthcare costs, along with the growing prevalence of chronic diseases, an aging population, and rising hospitalization rates, which have led to increased demand for ambulatory services in the region.
The market is competitive owing to the presence of several ambulatory surgery center providers. Market players are adopting various strategies, such as new service launches, partnerships & collaborations, and regional expansion to gain higher shares. For instance, in February 2023, Spire Orthopedic Partners partnered with Dutchess County Orthopedic Associates, making Spire one of the largest orthopedic platforms in the United States. This will enable the company to serve existing patients better and meet the increasing demand.
In July 2022, the Southeastern Spine Institute Ambulatory Surgery Center, an affiliate of United Surgical Partners International, introduced a robotic surgery program. The center is equipped with advanced robotic systems to improve the accuracy and effectiveness of total knee replacement surgery. Additionally, in January 2022, ValueHealth LLC announced that its JV partner Penn State Health had acquired shares in the Surgery Center of Lancaster.Some of the prominent players in the global ambulatory surgery centers market include:
Envision Healthcare Corporation
Pediatrix Medical Group
Healthway Medical Group
Prospect Medical Holdings, Inc.
Nexus Day Surgery Centre
Market size value in 2023
USD 125.9 billion
Revenue forecast in 2030
USD 191.5 billion
CAGR of 6.18% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD billion and CAGR from 2023 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Application, ownership, center type, region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Sweden; Norway; Denmark; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
CHSPSC, LLC.; Envision Healthcare Corporation; TH Medical; Pediatrix Medical Group; UNITEDHEALTH GROUP; Surgery Partners; Healthway Medical Group; SurgCenter; Prospect Medical Holdings, Inc.; Group Eifelhöhen-Klinik AG; Edward-Elmhurst Health; Nexus Day Surgery Centre
Free report customization (equivalent to up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope.
Pricing and purchase options
Avail of customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global ambulatory surgery centers market report based on application, ownership, center type,and region:
Application Outlook (Revenue, USD Billion, 2018 - 2030)
Pain Management/Spinal Injections
Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
Center Type Outlook (Revenue, USD Billion, 2018 - 2030)
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
b. North America dominated the ASC market with a share of around 35.28% in 2022. This is attributable to increasing government funding to advance primary care services and rising coverage for outpatient services.
b. Some key players operating in the ASC market include CHSPSC, LLC.; Envision Healthcare Corporation; TH Medical; Pediatrix Medical Group.; UNITEDHEALTH GROUP.; Surgery Partners; Healthway Medical Group; SurgCenter; Prospect Medical Holdings, Inc.; Group Eifelhöhen-Klinik AG; Edward-Elmhurst Health; Nexus Day Surgery Centre
b. Key factors that are driving the ASC market growth include increasing demand for minimally invasive surgeries, technological developments in surgical devices and equipment, and surgeons’ control over the choice of such equipment.
b. The global ambulatory surgery centers market size was estimated at USD 117.7 billion in 2022 and is expected to reach USD 125.9 billion in 2023.
b. The global ambulatory surgery centers market is expected to grow at a compound annual growth rate of 6.18% from 2023 to 2030 to reach USD 191.5 billion by 2030.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."